{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
INN:aligomanuxic acid [INN]
Source URL:
Class:
POLYMER
Status:
Investigational
Source:
Burns. Sep 2006;32(6):698-705.: Phase 3 Human clinical trial Completed N/A
Source URL:
Class:
POLYMER
Status:
Investigational
Source:
Ann Oncol. Mar 2008;19(3):520-6.: Phase 3 Human clinical trial Completed Stomach Neoplasms/mortality/surgery
Source URL:
Class:
POLYMER
Status:
Investigational
Source:
INN:evexomostat [INN]
Source URL:
Class:
POLYMER
Status:
Investigational
Source:
NCT03867851: Phase 2 Interventional Terminated Diabetes Mellitus, Type 1
(2021)
Source URL:
Class:
POLYMER
Status:
Investigational
Source:
NCT04365868: Phase 2/Phase 3 Interventional Active, not recruiting Prevention of Esophageal Varices
(2020)
Source URL:
Class:
POLYMER
Status:
Investigational
Source:
INN:pegsitacianine [INN]
Source URL:
Class:
POLYMER
Status:
Investigational
Source:
NCT04535947: Phase 2 Interventional Completed Dry Eye
(2020)
Source URL:
Class:
POLYMER
Status:
Investigational
Source:
INN:acetylcysteine zidrimer [INN]
Source URL:
Class:
POLYMER
Status:
Investigational
Source:
INN:livaraparin calcium [INN]
Source URL:
Class:
POLYMER
